UK markets open in 4 hours 32 minutes

MediPharm Labs Corp. (MLZ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.04900.0000 (0.00%)
At close: 08:26AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 20.43M
Enterprise value 10.46M
Trailing P/E 186.75
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.78
Price/book (mrq)0.59
Enterprise value/revenue 0.42
Enterprise value/EBITDA -0.93

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 322.19%
S&P500 52-week change 324.69%
52-week high 30.0700
52-week low 30.0303
50-day moving average 30.0520
200-day moving average 30.0459

Share statistics

Avg vol (3-month) 31.14k
Avg vol (10-day) 3N/A
Shares outstanding 5404.82M
Implied shares outstanding 6416.88M
Float 8387.33M
% held by insiders 14.53%
% held by institutions 10.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -36.78%
Operating margin (ttm)-26.39%

Management effectiveness

Return on assets (ttm)-12.28%
Return on equity (ttm)-26.29%

Income statement

Revenue (ttm)36.99M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)67.20%
Gross profit (ttm)N/A
EBITDA -9.43M
Net income avi to common (ttm)-13.61M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)17.18M
Total cash per share (mrq)0.04
Total debt (mrq)2.12M
Total debt/equity (mrq)4.24%
Current ratio (mrq)3.07
Book value per share (mrq)0.12

Cash flow statement

Operating cash flow (ttm)-10.81M
Levered free cash flow (ttm)4.38M